Harvest ETFs Announces September 2025 Distributions
OAKVILLE, Ontario–(BUSINESS WIRE)–Harvest Portfolios Group Inc. (“Harvest”) announces the following monthly distributions for Harvest ETFs for the... Read more.
Morningstar Plans to Acquire CRSP, Solidifying Position as a Top-Tier Global Index Provider
CHICAGO–(BUSINESS WIRE)–Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today announced it has entered into... Read more.
payabl. Strengthens Lithuanian Presence to Meet Demand in the Baltics
Esfira Zaka appointed General Manager of the Lithuanian entity, alongside her role as Group Chief Marketing Officer payabl. to expand local hiring as demand grows... Read more.
IonQ Achieves Significant Quantum Internet Milestone, Demonstrates Quantum Frequency Conversion to Telecom Wavelengths
Breakthrough paves the way for interconnecting quantum computers over vast distances by leveraging existing fiber optic infrastructure COLLEGE PARK, Md.–(BUSINESS... Read more.
From Cheese to Chai, ReposiTrak Welcomes 42 Suppliers to the Lineup Joining the Growing Food Traceability Network
Suppliers from multiple categories, including soft cheese and herb product companies, are part of the queue utilizing ReposiTrak for food traceability SALT LAKE... Read more.
Bioceres Crop Solutions and Colorado Wheat Research Foundation Partner to Advance Climate-Resilient HB4® Wheat in the U.S.
ROSARIO, Argentina & FORT COLLINS, Colorado–(BUSINESS WIRE)–Bioceres Crop Solutions Corp. (NASDAQ: BIOX) and the Colorado Wheat Research Foundation... Read more.
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma
PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #BMS—Bristol Myers Squibb (NYSE: BMY) today announced that the Phase 3 EXCALIBER-RRMM study evaluating iberdomide,... Read more.
Ferguson Files Form 8-K and Final Prospectus Supplement
NEWPORT NEWS, Va.–(BUSINESS WIRE)–On September 22, 2025, Ferguson Enterprises Inc. (the “Company”) made the following filings with the U.S.... Read more.
Virtuoso Surgical Robotic System Receives FDA Breakthrough Device Designation
NASHVILLE, Tenn.–(BUSINESS WIRE)–Virtuoso Surgical, Inc., a Nashville-based company developing a groundbreaking, entirely new class of robotic tools... Read more.
Drug Farm Announces Agreement with Cincinnati Children’s Hospital Medical Center to Explore ALPK1 Inhibitor, DF-003 as a Potential Treatment for Heart Disease and Blood Cancers Driven by Clonal Hematopoiesis
Dr. Daniel Starczynowski joins Drug Farm Scientific Advisory Board ALBANY, N.Y. & SHANGHAI–(BUSINESS WIRE)–Drug Farm, a private biotechnology company... Read more.